Toggle navigation
LOGO
About TTY
About TTY
Strategic Deployment
About Strategic Deployment
Global Operations
TTY Group
Management
Corporate Executives
Organization
Collaboration and Services
Licensing
Contract Development Manufacturing
PIC/S GMP Business Service
Distribution
Newsroom
Technology Development
Technology Development
Liposomes
Introduction
Pipeline
Microspheres
Introduction
Pipeline
Conventional Products
Introduction
Dosage Form
Formulation Capabilities
Formulation Development
Analytical Development
Process Development
Animal Studies
Functional Excipents
GMP Manufacturing
CMC Preparation
Manufacturing
Manufacturing
Cytotoxic Products
Non-cytotoxic Products
Product Areas
Product Areas
Oncology
Products
About TOT BU
Anti-Infection
Products
About TIT BU
Healthcare
Products
Investors
Investors
Investor Conference
Financials
Monthly Revenues
Financial Statements
Annual Report
Shareholder Services
Dividends
Shareholder's Meeting
List of Major Shareholders
Corporate Governance
Board of Directors
Sustainable Development Committee
Audit Committee
Remuneration Committee
Major Corporate Policies
Internal Audit
IP Management
Information Security
Careers
Careers
Philosophy
Salaries & Benefits
Attractive salary
Excellent benefits
Amicable environment
Positive activities
TTY Seeds
New Comer Socialization
Talent Development Program (TDP)
Join TTY
Professional challenges
Recruitment process
Transportation ways
Industry Academy Cooperation
Sustainability
Sustainability
Sustainability Report
Download
TCFD
SASB
Governance
Environmental
Energy & GHG Emission
Water Management
Air Pollution Control
Waste Management
Toxicity Management
TTY Actions
Social
Cancer Cares
Love for Society
TTY Rice
Awards
Employee Care
Salary & Benefits
Comprehensive Training
Occupational Safety & Health
Epidemic Prevention
Supplier
Supplier Assessment
Cold Chain Management
Contractor Management
En /
繁中
Previous
Next
Newsroom
2024/12/11
Announcement of TTY Biopharm's unaudited income information in November 2024
2024/11/13
Announcement of The Consolidated Financial Report for The 3rd Quarter of 2024
2024/11/11
Announcement of TTY Biopharm's unaudited income information in October 2024
2024/10/11
Announcement of TTY Biopharm's unaudited income information in September 2024
2024/9/11
Announcement of TTY Biopharm's unaudited income information in August 2024
+More
TTY Group
Financials
Monthly Revenues
Financial Statements
Annual Reports
Collaboration and Service
Licensing
Contract Design Manufacturing
PIC/S GMP Business Service
Distribution
Sustainability
Sustainability Report
Governance
Environmental
Social
Employee Care
Supplier
^
TOP
